Literature DB >> 21113395

Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibility.

J Alan Diehl1, Bhaskar Ponugoti.   

Abstract

Cell division depends upon the coordinated action of positive and negative regulatory factors that ensure high fidelity replication of the genome and its equivalent separation into daughter cells following cytokinesis. The role of positive factors such as the cyclin dependent kinases in promoting cell division is firmly established, as is the function of CDK inhibitors and phosphatases that antagonize CDKs. In addition to these, regulated protein destruction is now appreciated as essential for temporal regulation of cell cycle transitions. Protein degradation serves as an irreversible switch that ensures temporally regulated cell cycle transitions. Signal-dependent regulation of protein degradation is best understood with regard to the 26S proteasome. Proteins are directed to this machine subsequent to enzymatic transfer of a highly conserved small polypeptide, ubiquitin. The focus of this review is the regulatory molecules that direct the regulated attachment of ubiquitin, polyubiquitylation, to proteins destined for degradation as cells transition through the G1 phase into S-phase. During the past decade, it has become increasingly apparent that these molecules are critical mediators of normal cell proliferation and as such they are frequently deregulated in human cancers.

Entities:  

Year:  2010        PMID: 21113395      PMCID: PMC2991141          DOI: 10.1177/1947601910382902

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  90 in total

Review 1.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex.

Authors:  B A Schulman; A C Carrano; P D Jeffrey; Z Bowen; E R Kinnucan; M S Finnin; S J Elledge; J W Harper; M Pagano; N P Pavletich
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.

Authors:  Y Hosokawa; A Arnold
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

5.  Structural basis of dimerization-dependent ubiquitination by the SCF(Fbx4) ubiquitin ligase.

Authors:  Yunfeng Li; Bing Hao
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

6.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

7.  The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex.

Authors:  J A Hadwiger; C Wittenberg; M D Mendenhall; S I Reed
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  Mouse development and cell proliferation in the absence of D-cyclins.

Authors:  Katarzyna Kozar; Maria A Ciemerych; Vivienne I Rebel; Hirokazu Shigematsu; Agnieszka Zagozdzon; Ewa Sicinska; Yan Geng; Qunyan Yu; Shoumo Bhattacharya; Roderick T Bronson; Koichi Akashi; Piotr Sicinski
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

9.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

10.  Development of mice expressing a single D-type cyclin.

Authors:  Maria A Ciemerych; Anna M Kenney; Ewa Sicinska; Ilona Kalaszczynska; Roderick T Bronson; David H Rowitch; Humphrey Gardner; Piotr Sicinski
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

View more
  7 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 2.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

3.  Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours.

Authors:  Fabian Dominik Mairinger; Robert Fred Henry Walter; Dirk Theegarten; Thomas Hager; Claudia Vollbrecht; Daniel Christian Christoph; Karl Worm; Saskia Ting; Robert Werner; Georgios Stamatis; Thomas Mairinger; Hideo Baba; Konstantinos Zarogoulidis; Haidong Huang; Qiang Li; Kosmas Tsakiridis; Paul Zarogoulidis; Kurt Werner Schmid; Jeremias Wohlschlaeger
Journal:  J Cancer       Date:  2014-08-01       Impact factor: 4.207

4.  Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycle.

Authors:  Milagros J Tenga; Iulia M Lazar
Journal:  BMC Cancer       Date:  2014-09-24       Impact factor: 4.430

5.  Aberrant modulation of the BRCA1 and G1/S cell cycle pathways in alcoholic hepatitis patients with Mallory Denk Bodies revealed by RNA sequencing.

Authors:  Hui Liu; Ming Gong; Barbara A French; Guanghong Liao; Jun Li; Brittany Tillman; Samuel W French
Journal:  Oncotarget       Date:  2015-12-15

6.  Therapeutic targeting of cancer cell cycle using proteasome inhibitors.

Authors:  Namrata Rastogi; Durga Prasad Mishra
Journal:  Cell Div       Date:  2012-12-26       Impact factor: 5.130

7.  Effects of the Bone/Bone Marrow Microenvironments on Prostate Cancer Cells and CD59 Expression.

Authors:  Bo Yan; Yan Li; Shaoju Min; Peng Zhang; Bin Xu; Zhen Wang; Wei Zhang; Jiasheng Chen; Guangheng Luo; Chunxiao Liu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.